Regulatory allospecific T cell clones abrogate chronic allograft rejection

Journal of the American Society of Nephrology

Volumn 20, Issue 4, 2009, Pages 820-830

  Chandraker, Anil ^b,e   Waaga Gasser, Ana Maria ^a,b   Grimm, Martin R ^a   Lutz, Jens ^c   Lange, Volkmar ^a   Lenhard, Susanne M ^a,b   Aviles, Beatriz ^f   Kist van Holthe, Joana E ^b   Lebedeva, Tatiana ^b   Samsonov, Dimitry ^b   Meyer, Detlef ^a   Hancock, Wayne W ^d   Heemann, Uwe ^c   Gasser, Martin ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALLOANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; LEWIS RAT; LYMPHOCYTE CLONE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFER; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; TH1 CELL; TH2 CELL; WISTAR RAT;

EID: 65249149635     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008020164     Document Type: Article

References (35)

1. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Ruckert B, Karagiannidis C, Lambrecht BN, Hendriks RW, Crameri R, Akdis CA, Blaser K, Schmidt-Weber CB: GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5: e329, 2007
2. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76: 241-251, 1994
3. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA: Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 93: 13967-13972, 1996
4. Khoury SJ, Gallon L, Chen W, Betres K, Russell ME, Hancock WW, Carpenter CB, Sayegh MH, Weiner HL: Mechanisms of acquired thy- mic tolerance in experimental autoimmune encephalomyelitis: Thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 182: 357-366, 1995
5. Khoury SJ, Gallon L, Verburg RR, Chandraker A, Peach R, Linsley PS, Turka LA, Hancock WW, Sayegh MH: Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 157: 3700-3705, 1996
6. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA: CD28 -B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181: 1869-1874, 1995
7. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789 -3796, 2001
8. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S: Donor- type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft- versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196: 389 -399, 2002
9. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80: 707-718, 1995
10. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195: 603-616, 2002
11. Field EH, Gao Q, Chen NX, Rouse TM: Balancing the immune system for tolerance: A case for regulatory CD4 cells. Transplantation 64: 1-7, 1997
12. Nickerson P, Steiger J, Zheng XX, Steele AW, Steurer W, Roy-Chaudhury P, Strom TB: Manipulation of cytokine networks in transplantation: False hope or realistic opportunity for tolerance? Transplantation 63: 489-494, 1997
13. Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK: Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 63: 619 -624, 1997
14. Afzali B, Lombardi G, Lechler RI, Lord GM: The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148: 32-46, 2007
15. Chen Y, Wood KJ: Interleukin-23 and TH17 cells in transplantation immunity: Does 23+ 17 equal rejection? Transplantation 84: 1071-1074, 2007
16. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132, 2005
17. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141, 2005
18. Waaga AM, Gasser M, Kist-van Holthe JE, Najafian N, Muller A, Vella JP, Womer KL, Chandraker A, Khoury SJ, Sayegh MH: Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 107: 909-916, 2001
19. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest 106: 145-155, 2000
20. Gasser M, Waaga-Gasser AM, Kist-van Holthe JE, Yuan X, Lenhard SM, Abdallah KA, Chandraker A: Chronic rejection: Insights from a novel immunosuppressive-free model of kidney transplantation. J Am Soc Nephrol 15: 687-694, 2004
21. Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH: The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol 170: 2949 -2955, 2003
22. Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH: Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 93: 12439-12444, 1996
23. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A 92: 8729-8733, 1995
24. Bluestone JA, Thomson AW, Shevach EM, Weiner HL: What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 7: 650-654, 2007
25. Shirwan H: Chronic allograft rejection: Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 68: 715-726, 1999
26. Anderson DE, Sharpe AH, Hafler DA: The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system. Curr Opin Immunol 11: 677-683, 1999
27. Xu H, Heeger PS, Fairchild RL: Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity. J Immunol 159: 4217-4226, 1997
28. Sakurai J, Ohata J, Saito K, Miyajima H, Hirano T, Kohsaka T, Enomoto S, Okumura K, Azuma M: Blockade of CTLA-4 signals inhibits Th2- mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells. J Immunol 164: 664-669, 2000
29. Koksoy S, Elpek KG, Yolcu ES, Shirwan H: Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+ CD25+ Treg cells. Transplantation 79: 1492-1497, 2005
30. Kist-van Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Sam- sonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM: Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 62: 627-631, 2002
31. Izawa A, Sayegh MH, Chandraker A: The antagonism of calcineurin inhibitors and costimulatory blockers: Fact or fiction? Transplant Proc 36: 570S-573S, 2004
32. Waaga AM, Chandraker A, Spadafora-Ferreira M, Iyengar AR, Khoury SJ, Carpenter CB, Sayegh MH: Mechanisms of indirect allorecognition: Characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection. Transplantation 65: 876-883, 1998
33. Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH: Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 67: 1523-1532, 1999
34. Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM, 3rd, Tilney NL: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56: 643-650, 1993
35. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987